Track ICU Medical, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

ICU Medical, Inc. ICUI Open ICU Medical, Inc. in new tab

118.72 USD
P/E
3076.38
EPS
0.04
P/B
1.43
ROE
0.04
Beta
0.74
Target Price
177.50 USD
ICU Medical, Inc. logo

ICU Medical, Inc.

🧾 Earnings Recap – Q1 2026

ICU Medical's shares jumped 5.7% post-earnings, reflecting investor approval of steady organic growth in key businesses and improving margins despite ongoing portfolio adjustments and FDA-related delays in new pump hardware approvals.

  • Q1 revenue was $526 million, with 1% organic growth despite a 12% reported decline due to deconsolidation of the IV Solutions joint venture.
  • Consumables revenue grew 2% organically, while IV Systems posted stronger 6% organic growth, including record pump sales and robust capital equipment demand.
  • Vital Care revenue declined 14% organically, mainly driven by discontinuation of certain SKUs and portfolio rationalization; near-term organic revenue expected to be flat to slightly down.
  • Gross margins improved sequentially to above 41%, driven by favorable product mix in infusion businesses.
  • FDA has raised testing requirements for new Medfusion and CADD pump hardware, delaying launches but not indicating product issues; management prioritizes completion of expanded testing.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 6, 2026
P/E3076.38
EPS0.04
Book Value86.03
Price to Book1.43
Debt/Equity63.48
% Insiders3.787%
Growth
Revenue Growth-0.14%
Estimates
Forward P/E13.39
Forward EPS9.19
Target Mean Price177.50

DCF Valuation

Tweak assumptions to recompute fair value for ICU Medical, Inc. (ICUI)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

ICU Medical, Inc. Logo ICU Medical, Inc. Analysis (ICUI)

United States Health Care Official Website Stock

Is ICU Medical, Inc. a good investment? ICU Medical, Inc. (ICUI) is currently trading at 118.72 USD. Market analysts have a consensus price target of 177.50 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 3076.38. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: ICU Medical, Inc. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 9.19.

Investor FAQ

Does ICU Medical, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is ICU Medical, Inc.?

ICU Medical, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 0.04.

Company Profile

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Exchange Ticker
NMS (United States) ICUI

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
March 18, 2002 1.500000
April 1, 1993 1.500000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion